Medical Properties Trust, Inc. $MPW Shares Sold by Truist Financial Corp

Truist Financial Corp lessened its stake in Medical Properties Trust, Inc. (NYSE:MPW) by 20.0% during the second quarter, HoldingsChannel.com reports. The firm owned 16,244 shares of the real estate investment trust’s stock after selling 4,066 shares during the period. Truist Financial Corp’s holdings in Medical Properties Trust were worth $70,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. Charles Schwab Investment Management Inc. raised its stake in shares of Medical Properties Trust by 13.4% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 10,020,568 shares of the real estate investment trust’s stock valued at $60,424,000 after purchasing an additional 1,182,028 shares in the last quarter. Allianz Asset Management GmbH raised its stake in Medical Properties Trust by 43.2% during the first quarter. Allianz Asset Management GmbH now owns 7,134,629 shares of the real estate investment trust’s stock worth $43,022,000 after acquiring an additional 2,152,861 shares during the period. Northern Trust Corp raised its stake in Medical Properties Trust by 1.5% during the first quarter. Northern Trust Corp now owns 6,404,674 shares of the real estate investment trust’s stock worth $38,620,000 after acquiring an additional 95,525 shares during the period. Wilsey Asset Management Inc. raised its stake in Medical Properties Trust by 6.1% during the second quarter. Wilsey Asset Management Inc. now owns 4,927,568 shares of the real estate investment trust’s stock worth $21,238,000 after acquiring an additional 281,591 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Medical Properties Trust by 11.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,086,848 shares of the real estate investment trust’s stock worth $24,644,000 after acquiring an additional 410,374 shares during the period. Institutional investors and hedge funds own 71.79% of the company’s stock.

Medical Properties Trust Price Performance

Shares of NYSE:MPW opened at $5.15 on Monday. The firm’s 50 day moving average is $4.76 and its two-hundred day moving average is $4.71. Medical Properties Trust, Inc. has a 52 week low of $3.51 and a 52 week high of $6.34. The firm has a market capitalization of $3.10 billion, a P/E ratio of -2.15 and a beta of 1.39. The company has a current ratio of 2.76, a quick ratio of 2.76 and a debt-to-equity ratio of 2.00.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Medical Properties Trust had a negative net margin of 155.20% and a negative return on equity of 28.80%. The firm had revenue of $240.36 million during the quarter, compared to analyst estimates of $231.90 million. During the same quarter in the previous year, the business posted $0.23 EPS. Medical Properties Trust’s revenue for the quarter was down 9.8% compared to the same quarter last year. Analysts anticipate that Medical Properties Trust, Inc. will post 0.78 earnings per share for the current year.

Medical Properties Trust Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, October 9th. Shareholders of record on Thursday, September 11th were paid a $0.08 dividend. The ex-dividend date was Thursday, September 11th. This represents a $0.32 annualized dividend and a dividend yield of 6.2%. Medical Properties Trust’s dividend payout ratio (DPR) is presently -13.39%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on MPW shares. Wells Fargo & Company dropped their price objective on shares of Medical Properties Trust from $5.00 to $4.50 and set an “underweight” rating on the stock in a research note on Wednesday, August 27th. Wall Street Zen lowered shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Saturday, July 5th. Royal Bank Of Canada dropped their price objective on shares of Medical Properties Trust from $5.00 to $4.50 and set a “sector perform” rating on the stock in a research note on Monday, June 30th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Medical Properties Trust in a research note on Wednesday, October 8th. Finally, Zacks Research upgraded shares of Medical Properties Trust from a “strong sell” rating to a “hold” rating in a research note on Wednesday, August 20th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average price target of $5.40.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.